Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Rzyman

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|March 13, 2015
Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experienceWitold Rzyman, Robert Dziedzic, Małgorzata Jelitto-Górska, et al.
Journal of Cardiovascular Development and Disease|January 22, 2024
Evaluation of Conventional Cardiovascular Risk Factors and Ordinal Coronary Artery Calcium Scoring in a Lung Cancer Screening CohortPiotr Kasprzyk, Aleksandra Undrunas, Katarzyna Dziadziuszko, et al.
Plos One|April 3, 2019
Folate/homocysteine metabolism and lung cancer risk among smokersAnna Stanisławska-Sachadyn, Joanna Borzyszkowska, Michał Krzemiński, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Serum mass profile signature as a biomarker of early lung cancerPiotr Widlak, Monika Pietrowska, Joanna Polanska, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphismAmelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Interactive Cardiovascular and Thoracic Surgery|March 20, 2019
Ten years of experience in lung cancer screening in Gdańsk, Poland: a comparative study of the evaluation and surgical treatment of 14 200 participants of 2 lung cancer screening programmes†Marcin Ostrowski, Tomasz Marjański, Robert Dziedzic, et al.
International Journal of Molecular Sciences|July 9, 2022
What Inhibits Natural Killers' Performance in TumourInes Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
Translational Lung Cancer Research|March 15, 2021
Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland-a comparative studyMarcin Ostrowski, Franciszek Bińczyk, Tomasz Marjański, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case reportRafal Dziadziuszko, Anna Siemiatkowska, Janusz Limon, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 13, 2017
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer RegistryRobert Dziedzic, Wojciech Zurek, Tomasz Marjanski, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Polskie Archiwum Medycyny Wewnetrznej|March 13, 2015
Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experienceWitold Rzyman, Robert Dziedzic, Małgorzata Jelitto-Górska, et al.
Journal of Cardiovascular Development and Disease|January 22, 2024
Evaluation of Conventional Cardiovascular Risk Factors and Ordinal Coronary Artery Calcium Scoring in a Lung Cancer Screening CohortPiotr Kasprzyk, Aleksandra Undrunas, Katarzyna Dziadziuszko, et al.
Plos One|April 3, 2019
Folate/homocysteine metabolism and lung cancer risk among smokersAnna Stanisławska-Sachadyn, Joanna Borzyszkowska, Michał Krzemiński, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Serum mass profile signature as a biomarker of early lung cancerPiotr Widlak, Monika Pietrowska, Joanna Polanska, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphismAmelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Interactive Cardiovascular and Thoracic Surgery|March 20, 2019
Ten years of experience in lung cancer screening in Gdańsk, Poland: a comparative study of the evaluation and surgical treatment of 14 200 participants of 2 lung cancer screening programmes†Marcin Ostrowski, Tomasz Marjański, Robert Dziedzic, et al.
International Journal of Molecular Sciences|July 9, 2022
What Inhibits Natural Killers' Performance in TumourInes Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
Translational Lung Cancer Research|March 15, 2021
Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland-a comparative studyMarcin Ostrowski, Franciszek Bińczyk, Tomasz Marjański, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case reportRafal Dziadziuszko, Anna Siemiatkowska, Janusz Limon, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 13, 2017
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer RegistryRobert Dziedzic, Wojciech Zurek, Tomasz Marjanski, et al.
Pageof 8